Analgesics Market
Market Insights on Analgesics covering sales outlook, demand forecast & up-to-date key trends
Analgesics Market By Drug Class (Opioids, NSAIDs, Local Anesthetics, Acetaminophen), Indication (Surgical Pain, Cancer Pain, Neuropathic Pain), Route of Administration (Oral, Parenteral, Transdermal) & Region - Forecast 2021-2031
Analgesics Market Snapshot
[318 Pages Report] Analgesics Market to register 5.6% CAGR between 2021 and 2031, According to Future Market Insights (FMI). The total sales of analgesics are expected to reach US$ 77.3 Bn in 2021. As per FMI, opioids sales accounted for 50.3% of the market share in 2020.
Driven by positive demand outlook, the analgesics market held nearly 93% of sales in pain management market in 2020.
Data Points |
Market Insights |
Analgesics Market Estimated Value (2021) |
US$ 77.3 Bn |
Analgesics Market Estimated Value (2031) |
US$ 133.5 Bn |
CAGR 2021-2031 |
5.6% |
Let us know your requirement to get
100% FREE customization
Sales Analysis of Analgesics Market: 2016 to 2020 Vs 2021 to 2031 Market Outlook
The global analgesics market expanded at 4.4% CAGR over the past 5 years. Analgesics is defined as a term which encompasses a class of drugs designed to provide pain relief without causing loss in consciousness. Opioid analgesics has been adopted worldwide and are recognized as the most effective and widely used drugs for the treatment of severe pain.
The global demand of analgesics arises from the goal of improving healthcare outcomes. This includes pain management, which requires a multidisciplinary approach to administer. Apart from this, the formulation of opioid analgesics with abuse-deterrent properties by manufacturers has created a high demand for analgesics over the globe.
- According to the WHO, there are only about 14% of people over the globe who receive palliative care. Additionally, each year, the global estimation of people in need of palliative care is about 40 million. The low and middle-income economies carry over 78% of that population metric.
The global rise in the prevalence of neuropathic and chronic pain, as well as advancements in pain management measures are key factors pushing the global analgesics sales. The market is expected to expand at a CAGR of close to 5.6% over the forthcoming decade.
What are the Key Opportunities for Analgesics Manufacturers?
Many people find a certain dose of opioids to be ineffective in cases of severe pain. These patients need to take a higher doses of drugs to subdue the pain, which eventually makes them opioid tolerant, and in some cases, addicted. Hence, commercializing opioid-tolerant drugs is expected to be one of the main opportunities for players in the opioid drugs market. This will also help in reducing the side effects related to or caused by increased consumption of opioid drugs.
For pain management, opioids are largely used in North America and Western Europe but due to increasing usage of opioids for non-medical purposes, the governing bodies of respective countries are encouraging doctors to prescribe non-opioid analgesics, which provides an opportunity for the companies to introduce novel non-opioid drugs.
The introduction of non-opioid analgesics in markets such as Asia and Africa, where the opioid as well as non-opioid drugs with novel drug delivery system are not widely available for pain management, creates opportunities for the growth of the analgesics market.
The rising cases of opioid dependency as well as the abuse of painkillers have led to the development of different forms of abuse-deterrent technologies. Expansion of manufacturing facilities across regions with scarce novel drug delivery systems will create opportunity for sales growth in the analgesics market over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Sales of Analgesics?
Due to the severity of abusive opioids and their misuse, physicians have reduced their prescription for pain management, which has decreased their overall sales in the global analgesics market. According to the International Association for the Study of Pain (IASP), around 20–30% of opioids prescribed for chronic pain are being misused. Besides this, as per the association, up to 10% of the total opioid consumers are addicted to it.
The consumption of opioids per capita is low in Asian countries. As per the Global Opioids Policy Initiative (GOPI), factors responsible for the low usage of opioids in Asia and Africa are requirements of complete cost of payment by the patient, registration of patient receiving opioid prescription, unavailability of some opioid formulations and physician requirement to receive permission for opioid prescriptions.
These factors might restrain the analgesics market growth in the region.
Analgesics Market - Country-wise Insights
What Makes the U.S. Analgesics Market Dominant in North America?
The U.S. dominates the North America analgesics market with a total share of 86.5% in 2021, and is projected to continue exhibiting high demand through the course of the forecast period.
As per the documentations in 2016 by the National Health Institute, over 20% of adults in the U.S. suffer from chronic pain and 8% had high-impact chronic pain. This factor has leveraged analgesics demand in the country.
The Canadian Pain Task Force (CPTF) by the government of Canada was established in 2019 to deliver advice to guide the federal government towards better-quality methods for prevention and management of chronic pain, a diagnosis affecting nearly 8 million people living in Canada.
These initiatives will continue favoring expansion of the analgesics market in North America.
Why is Germany Analgesics Market Considered Lucrative within Europe?
Germany dominates the Europe analgesics market, with a share of 23.2%. Germany’s dominance is supported by the rising number of over the counter (OTC) pharmacies in the country.
The trend of self-medication in Germany is highly prevalent. Sales of non-prescription analgesics via OTC pharmacies in Germany has been characterized as one of the main drivers of sales of analgesics in the country.
What Makes China Analgesics Market Highly Attractive?
China holds 54.3% share in the East Asia market, and is projected to expand at a CAGR of over 9.3%. According to a research published in the Journal of Pharmaceutical Policy and Practice, evaluation of analgesic utilization in public hospitals in China presented a rapid increase in the utilization of analgesics in China. Furthermore, the utilization of NSAID’s and opioids showed a higher trend than other types of analgesics.
The introduction of non-opioid analgesics in the country is expected promote the sales of analgesics in China over the forecast period.
What is the Japan Analgesics Market Outlook?
In 2020, Japan accounted for 31.8% of the East Asia analgesics market and is projected to expand at a CAGR of 6.6% from 2021 to 2031. There has been a swift trend favoring the demand aspect of analgesic utilization. Japan registered high sales of analgesics in 2018 and the demand was mostly concentrated in older or geriatric population aiming to achieve better quality of life.

An unified Market Research Subscription Platform, built for today’s disparate research needs.
Analgesics Market - Category-wise Insights
Which Analgesics Drug Class is Witnessing Maximum Demand?
By drug type, the demand for NSAID’s is projected to increase at a CAGR of 4.1% during the forecast period. High demand for this drug class is because of the rising burden of chronic pain and inflammation globally.
By Indication, Which Segment is leading the Analgesics Market?
Surgical pain holds a revenue share of 53.3% in 2021 and is projected to continue accounting for over half of sales in the market by 2031. This trend in market revenue share is associated with the increasing adoption of surgical procedures worldwide.
Which is the Preferred Distribution Channel for Analgesics Sales?
Based on distribution channel, hospital pharmacies led the analgesics market with more than 30.1% market share in 2020. The controlled sales of opioid analgesics contribute to a higher market share for hospital pharmacies.
Analgesics Market - Competitive Landscape
Key players are focusing on novel and innovative approaches for the development of non-opioid or non-addictive formulations for pain management. The strategy of expansion, new product launches, and approvals, by key manufacturers is further strengthening their market presence.
- In October 2017, Pfizer Inc., and other Leading health care organizations AmerisourceBergen, Blue Cross Blue Shield Association, and Prime Therapeutics are joining Walgreens (nation's largest drugstore chains) to combat the national opioid abuse crisis by expanding the availability of safe medication disposal kiosks to an additional 900 Walgreens stores.
- In August 2018, Sun Pharma launched Volini Maxx, a pain relief spray.
Besides these, mergers and acquisitions have emerged as key growth strategies adopted by market players. Leading companies are strengthening their product portfolio and global footprint through acquisitions.
For instance:
- In May 2020, Assertio Therapeutics, Inc. merged with Zyla Life Sciences. The merger created a growing commercial pharmaceutical company with neurology, inflammation, and pain products.
Report Scope as per Analgesics Industry Analysis
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2016-2020 |
Analgesics Market Analysis |
US$ Mn for Value |
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
Key Market Segments Covered |
Drug Class, Indication, Route of Administration, Distribution Channel, and Region |
Key Companies Profiled |
|
Pricing |
Available upon Request |
Key Market Segments Covered in Analgesics Market Research
By Drug Class:
- Opioids
- Morphine
- Codiene
- Fentanyl
- Meperidine
- Methadone
- Tramadol
- Oxycodone
- Dextromethorphan
- Buprenorphine
- Others
- NSAIDs
- Local Anesthetics
- Acetaminophen
By Indication:
- Surgical pain
- Cancer Pain
- Neuropathic pain
- Others
By Route of Administration:
- Oral
- Parenteral
- Transdermal
- Others
By Distribution Channel:
- Hospital pharmacies
- Retail pharmacies
- Drug Stores
- Online pharmacies
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
The global analgesics market is worth US$ 73.6 Bn at present, and is set to expand by ~1.7X over the next ten years.
The analgesics market is expected to reach US$ 133.6 Bn by the end of 2031, with sales revenue increasing at 5.6% CAGR.
From 2016-2020, the market for analgesics expanded at the rate of 4.4%, owing to rise in research and development opportunities with reference to non-opioid analgesics.
Commercialization of non-abuse opioids, adoption of opioids maintenance treatment (OMT) to treat opioids dependence (OD), and partnerships and collaborations for development of non-opioid analgesics are some of the key trends being witnessed in this marketplace.
The U.S., China, Canada, Germany and France are expected to drive demand for analgesics.
North America is one of the key markets for analgesics. The U.S. is expected to account over 85.7% of the North America market.
Demand for analgesics in Europe is expected to register growth at 5.3% CAGR over the next ten years.
The U.S., Germany and China are key producers of analgesics.
The China analgesics market will account for 54.3% in East Asia. Japan holds a revenue share of 31.8% in the region.
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Drug Adoption / Usage Analysis
4.2. Key Strategies Adopted By Manufactures
4.3. Regulatory Scenario
5. Key Inclusion
5.1. Number of Post-Operative Patients in U.S., Japan and Global
5.2. Cross Sectional Analysis on Opioid Drug by Indication, U.S.
5.2.1. Morphine
5.2.2. Fentanyl
5.2.3. Buprenorphine
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increasing Prevalence of Chronic Disease and Surgical Procedures
6.2.2. Increasing Prevalence of Neuropathic and Chronic pain
6.2.3. Elevating Awareness about Palliative Care and Pain Management
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
6.4. Value Chain Analysis
7. COVID19 Crisis Analysis
7.1.1. Current COVID19 Statistics and Probable Future Impact
7.1.2. Current GDP Projection and Probable Impact
7.1.3. Current Economic Projection as compared to 2008 Economic analysis
7.1.4. COVID19 and Impact Analysis
7.1.4.1. Revenue By Product
7.1.4.2. Revenue By Country
8. Global Analgesics Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031
8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, By Drug Class
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2021–2031
9.3.1. Opioids
9.3.1.1. Morphine
9.3.1.2. Codeine
9.3.1.3. Fentanyl
9.3.1.4. Meperidine
9.3.1.5. Methadone
9.3.1.6. Tramadol
9.3.1.7. Oxycodone
9.3.1.8. Dextromethorphan
9.3.1.9. Buprenorphine
9.3.1.10. Others
9.3.2. NSAIDs
9.3.3. Local Anaesthetics
9.3.4. Acetaminophen
9.4. Market Attractiveness Analysis By Drug Class
10. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Indication, 2021 – 2031
10.3.1. Surgical Pain
10.3.2. Cancer Pain
10.3.3. Neuropathic Pain
10.3.4. Other
10.4. Market Attractiveness Analysis By Indications
11. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Route of Administration
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Route of Administration, 2021–2031
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Transdermal
11.3.4. Others
11.4. Market Attractiveness Analysis By Route of Administration
12. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021–2031
12.3.1. Hospitals
12.3.2. Retail Pharmacies
12.3.3. Drug Stores
12.3.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021–2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis By Region
14. North America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
14.3.1. By Drug Class
14.3.2. By Indication
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.3.5. By Country
14.3.5.1. U.S.
14.3.5.2. Canada
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints-Impact Analysis
15. Latin America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
15.3.1. By Drug Class
15.3.2. By Indication
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.3.5. By Country
15.3.5.1. Brazil
15.3.5.2. Mexico
15.3.5.3. Argentina
15.3.5.4. Rest of Latin America
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints-Impact Analysis
16. Europe Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
16.3.1. By Drug Class
16.3.2. By Indication
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.3.5. By Country
16.3.5.1. Germany
16.3.5.2. Italy
16.3.5.3. France
16.3.5.4. U.K.
16.3.5.5. Spain
16.3.5.6. BENELUX
16.3.5.7. Russia
16.3.5.8. Rest of Europe
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints-Impact Analysis
17. South Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
17.3.1. By Drug Class
17.3.2. By Indication
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.3.5. By Country
17.3.5.1. India
17.3.5.2. Thailand
17.3.5.3. Indonesia
17.3.5.4. Malaysia
17.3.5.5. Rest of South Asia
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints-Impact Analysis
18. East Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
18.3.1. By Drug Class
18.3.2. By Indication
18.3.3. By Route of Administration
18.3.4. By Distribution Channel
18.3.5. By Country
18.3.5.1. China
18.3.5.2. Japan
18.3.5.3. South Korea
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints-Impact Analysis
19. Oceania Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
19.3.1. By Drug Class
19.3.2. By Indication
19.3.3. By Route of Administration
19.3.4. By Distribution Channel
19.3.5. By Country
19.3.5.1. Australia
19.3.5.2. New Zealand
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints-Impact Analysis
20. Middle East and Africa Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
20.3.1. By Drug Class
20.3.2. By Indication
20.3.3. By Route of Administration
20.3.4. By Distribution Channel
20.3.5. By Country
20.3.5.1. GCC Countries
20.3.5.2. Turkey
20.3.5.3. Northern Africa
20.3.5.4. South Africa
20.3.5.5. Rest of Middle East and Africa
20.4. Market Attractiveness Analysis
20.5. Drivers and Restraints-Impact Analysis
21. Key and Emerging Countries Analgesics Market Analysis
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Analgesics Market Analysis
21.2.1. By Drug Class
21.2.2. By Indication
21.2.3. By Route of Administration
21.2.4. By Distribution Channel
21.3. Canada Analgesics Market Analysis
21.3.1. By Drug Class
21.3.2. By Indication
21.3.3. By Route of Administration
21.3.4. By Distribution Channel
21.4. Mexico Analgesics Market Analysis
21.4.1. By Drug Class
21.4.2. By Indication
21.4.3. By Route of Administration
21.4.4. By Distribution Channel
21.5. Brazil Analgesics Market Analysis
21.5.1. By Drug Class
21.5.2. By Indication
21.5.3. By Route of Administration
21.5.4. By Distribution Channel
21.6. Germany Analgesics Market Analysis
21.6.1. By Drug Class
21.6.2. By Indication
21.6.3. By Route of Administration
21.6.4. By Distribution Channel
21.7. Italy Analgesics Market Analysis
21.7.1. By Drug Class
21.7.2. By Indication
21.7.3. By Route of Administration
21.7.4. By Distribution Channel
21.8. France Analgesics Market Analysis
21.8.1. By Drug Class
21.8.2. By Indication
21.8.3. By Route of Administration
21.8.4. By Distribution Channel
21.9. U.K. Analgesics Market Analysis
21.9.1. By Drug Class
21.9.2. By Indication
21.9.3. By Route of Administration
21.9.4. By Distribution Channel
21.10. Spain Analgesics Market Analysis
21.10.1. By Drug Class
21.10.2. By Indication
21.10.3. By Route of Administration
21.10.4. By Distribution Channel
21.11. BENELUX Analgesics Market Analysis
21.11.1. By Drug Class
21.11.2. By Indication
21.11.3. By Route of Administration
21.11.4. By Distribution Channel
21.12. Russia Analgesics Market Analysis
21.12.1. By Drug Class
21.12.2. By Indication
21.12.3. By Route of Administration
21.12.4. By Distribution Channel
21.13. China Analgesics Market Analysis
21.13.1. By Drug Class
21.13.2. By Indication
21.13.3. By Route of Administration
21.13.4. By Distribution Channel
21.14. Japan Analgesics Market Analysis
21.14.1. By Drug Class
21.14.2. By Indication
21.14.3. By Route of Administration
21.14.4. By Distribution Channel
21.15. South Korea Analgesics Market Analysis
21.15.1. By Drug Class
21.15.2. By Indication
21.15.3. By Route of Administration
21.15.4. By Distribution Channel
21.16. India Analgesics Market Analysis
21.16.1. By Drug Class
21.16.2. By Indication
21.16.3. By Route of Administration
21.16.4. By Distribution Channel
21.17. ASEAN Analgesics Market Analysis
21.17.1. By Drug Class
21.17.2. By Indication
21.17.3. By Route of Administration
21.17.4. By Distribution Channel
21.18. Australia Analgesics Market Analysis
21.18.1. By Drug Class
21.18.2. By Indication
21.18.3. By Route of Administration
21.18.4. By Distribution Channel
21.19. New Zealand Analgesics Market Analysis
21.19.1. By Drug Class
21.19.2. By Indication
21.19.3. By Route of Administration
21.19.4. By Distribution Channel
21.20. GCC Countries Analgesics Market Analysis
21.20.1. By Drug Class
21.20.2. By Indication
21.20.3. By Route of Administration
21.20.4. By Distribution Channel
21.21. Turkey Analgesics Market Analysis
21.21.1. By Drug Class
21.21.2. By Indication
21.21.3. By Route of Administration
21.21.4. By Distribution Channel
21.22. South Africa Analgesics Market Analysis
21.22.1. By Drug Class
21.22.2. By Indication
21.22.3. By Route of Administration
21.22.4. By Distribution Channel
22. Market Structure Analysis
22.1. Market Share Analysis
22.2. Market Analysis by Tier of Companies
22.3. Market Concentration
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Deep Dive
23.2.1. Pfizer Inc.
23.2.1.1. Overview
23.2.1.2. Product Offering
23.2.1.3. Regional Footprint
23.2.1.4. Strategy Overview
23.2.1.4.1. Marketing Strategy
23.2.1.4.2. Product Strategy
23.2.1.4.3. Channel Strategy
23.2.2. Sun Pharmaceutical Industries, Inc.
23.2.2.1. Overview
23.2.2.2. Product Offering
23.2.2.3. Regional Footprint
23.2.2.4. Strategy Overview
23.2.2.4.1. Marketing Strategy
23.2.2.4.2. Product Strategy
23.2.2.4.3. Channel Strategy
23.2.3. Sanofi SA
23.2.3.1. Overview
23.2.3.2. Product Offering
23.2.3.3. Regional Footprint
23.2.3.4. Strategy Overview
23.2.3.4.1. Marketing Strategy
23.2.3.4.2. Product Strategy
23.2.3.4.3. Channel Strategy
23.2.4. AbbVie Inc. (Allergan plc)
23.2.4.1. Overview
23.2.4.2. Product Offering
23.2.4.3. Regional Footprint
23.2.4.4. Strategy Overview
23.2.4.4.1. Marketing Strategy
23.2.4.4.2. Product Strategy
23.2.4.4.3. Channel Strategy
23.2.5. Teva Pharmaceuticals
23.2.5.1. Overview
23.2.5.2. Product Offering
23.2.5.3. Regional Footprint
23.2.5.4. Strategy Overview
23.2.5.4.1. Marketing Strategy
23.2.5.4.2. Product Strategy
23.2.5.4.3. Channel Strategy
23.2.6. Boehringer Ingelheim International GmbH
23.2.6.1. Overview
23.2.6.2. Product Offering
23.2.6.3. Regional Footprint
23.2.6.4. Strategy Overview
23.2.6.4.1. Marketing Strategy
23.2.6.4.2. Product Strategy
23.2.6.4.3. Channel Strategy
23.2.7. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
23.2.7.1. Overview
23.2.7.2. Product Offering
23.2.7.3. Regional Footprint
23.2.7.4. Strategy Overview
23.2.7.4.1. Marketing Strategy
23.2.7.4.2. Product Strategy
23.2.7.4.3. Channel Strategy
23.2.8. Endo Pharmaceuticals Inc.
23.2.8.1. Overview
23.2.8.2. Product Offering
23.2.8.3. Regional Footprint
23.2.8.4. Strategy Overview
23.2.8.4.1. Marketing Strategy
23.2.8.4.2. Product Strategy
23.2.8.4.3. Channel Strategy
23.2.9. Purdue Pharmaceuticals L.P.
23.2.9.1. Overview
23.2.9.2. Product Offering
23.2.9.3. Regional Footprint
23.2.9.4. Strategy Overview
23.2.9.4.1. Marketing Strategy
23.2.9.4.2. Product Strategy
23.2.9.4.3. Channel Strategy
23.2.10. Assertio Therapeutics, Inc.
23.2.10.1. Overview
23.2.10.2. Product Offering
23.2.10.3. Regional Footprint
23.2.10.4. Strategy Overview
23.2.10.4.1. Marketing Strategy
23.2.10.4.2. Product Strategy
23.2.10.4.3. Channel Strategy
23.2.11. Mallinckrodt Pharmaceuticals
23.2.11.1. Overview
23.2.11.2. Product Offering
23.2.11.3. Regional Footprint
23.2.11.4. Strategy Overview
23.2.11.4.1. Marketing Strategy
23.2.11.4.2. Product Strategy
23.2.11.4.3. Channel Strategy
23.2.12. Bayer AG
23.2.12.1. Overview
23.2.12.2. Product Offering
23.2.12.3. Regional Footprint
23.2.12.4. Strategy Overview
23.2.12.4.1. Marketing Strategy
23.2.12.4.2. Product Strategy
23.2.12.4.3. Channel Strategy
23.2.13. GlaxoSmithKline plc.
23.2.13.1. Overview
23.2.13.2. Product Offering
23.2.13.3. Regional Footprint
23.2.13.4. Strategy Overview
23.2.13.4.1. Marketing Strategy
23.2.13.4.2. Product Strategy
23.2.13.4.3. Channel Strategy
23.2.14. Bausch Health Companies Inc.
23.2.14.1. Overview
23.2.14.2. Product Offering
23.2.14.3. Regional Footprint
23.2.14.4. Strategy Overview
23.2.14.4.1. Marketing Strategy
23.2.14.4.2. Product Strategy
23.2.14.4.3. Channel Strategy
23.2.15. Novartis AG
23.2.15.1. Overview
23.2.15.2. Product Offering
23.2.15.3. Regional Footprint
23.2.15.4. Strategy Overview
23.2.15.4.1. Marketing Strategy
23.2.15.4.2. Product Strategy
23.2.15.4.3. Channel Strategy
23.2.16. Others
23.2.16.1. Overview
23.2.16.2. Product Offering
23.2.16.3. Regional Footprint
23.2.16.4. Strategy Overview
23.2.16.4.1. Marketing Strategy
23.2.16.4.2. Product Strategy
23.2.16.4.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 04: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 05: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 06: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 07: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 08: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 09: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 10: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 11: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 12: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 13: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 15: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 16: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 17: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 18: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 19: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 20: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 21: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 22: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 23: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 24: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 25: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 26: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 27: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 28: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 29: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 30: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 31: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 32: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 33: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 34: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 35: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 36: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 37: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 38: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 39: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 40: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 41: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 42: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01 : Global Analgesics Market Value (US$ Mn) Forecast, 2021 – 2031
Figure 02 : Global Analgesics Market Share, By Drug Class (2021)
Figure 03 : Global Analgesics Market Share, By Region (2021)
Figure 04: Global Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 05: Global Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031
Figure 06: Global Analgesics Market Absolute $ Opportunity Analysis, 2021-2031
Figure 07: Global Analgesics Market Analysis By Drug Class–2021 & 2031
Figure 08: Global Analgesics Market Y-o-Y Growth Projections By Drug Class, 2021-2031
Figure 09: Global Analgesics Market Attractiveness, By Drug Class
Figure 10: Global Analgesics Market Analysis By Indication–2021 & 2031
Figure 11: Global Analgesics Market Y-o-Y Growth Projections By Indication, 2021-2031
Figure 12: Global Analgesics Market Attractiveness, By Indication
Figure 13: Global Analgesics Market Analysis By Route of Administration – 2021 & 2031
Figure 14: Global Analgesics Market Y-o-Y Growth Projections By Route of Administration, 2021-2031
Figure 15: Global Analgesics Market Attractiveness, By Route of Administration
Figure 16: Global Analgesics Market Analysis By Distribution Channel–2021 & 2031
Figure 17: Global Analgesics Market Y-o-Y Growth Projections By Distribution Channel, 2021-2031
Figure 18: Global Analgesics Market Attractiveness, By Distribution Channel
Figure 19: Global Analgesics Market Analysis by Region–2021 & 2031
Figure 20: Global Analgesics Market Y-o-Y Growth Projections by Region, 2021-2031
Figure 21: Global Analgesics Market Attractiveness, By Region
Figure 22: North America Analgesics Market Share, By Drug Class, 2021 (E)
Figure 23: North America Analgesics Market Share, By Indication, 2021 (E)
Figure 24: North America Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 25: North America Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 26: North America Analgesics Market Share, By Country, 2021 (E)
Figure 27: North America Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 28: North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 29: North America Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 30: North America Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 31: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 32: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 33: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 34: Latin America Analgesics Market Share, By Drug Class, 2021 (E)
Figure 35: Latin America Analgesics Market Share, By Indication, 2021 (E)
Figure 36: Latin America Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 37: Latin America Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 38: Latin America Analgesics Market Share, By Country, 2021 (E)
Figure 39: Latin America Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 40: Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 41: Latin America Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 42: Latin America Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 43: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 44: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 45: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 46: Europe Analgesics Market Share, By Drug Class, 2021 (E)
Figure 47: Europe Analgesics Market Share, By Indication, 2021 (E)
Figure 48: Europe Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 49: Europe Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 50: Europe Analgesics Market Share, By Country, 2021 (E)
Figure 51: Europe Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 52: Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 53: Europe Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 54: Europe Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 55: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 56: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 57: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 58: South Asia Analgesics Market Share, By Drug Class, 2021 (E)
Figure 59: South Asia Analgesics Market Share, By Indication, 2021 (E)
Figure 60: South Asia Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 61: South Asia Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 62: South Asia Analgesics Market Share, By Country, 2021 (E)
Figure 63: South Asia Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 64: South Asia Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 65: South Asia Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 66: South Asia Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 67: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 68: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 69: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 70: East Asia Analgesics Market Share, By Drug Class, 2021 (E)
Figure 71: East Asia Analgesics Market Share, By Indication, 2021 (E)
Figure 72: East Asia Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 73: East Asia Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 74: East Asia Analgesics Market Share, By Country, 2021 (E)
Figure 75: East Asia Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 76: East Asia Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 77: East Asia Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 78: East Asia Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 79: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 80: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 81: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 82: Oceania Analgesics Market Share, By Drug Class, 2021 (E)
Figure 83: Oceania Analgesics Market Share, By Indication, 2021 (E)
Figure 84: Oceania Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 85: Oceania Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 86: Oceania Analgesics Market Share, By Country, 2021 (E)
Figure 87: Oceania Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 88: Oceania Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 89: Oceania Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 90: Oceania Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 91: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 92: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 93: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 94: MEA Analgesics Market Share, By Drug Class, 2021 (E)
Figure 95: MEA Analgesics Market Share, By Indication, 2021 (E)
Figure 96: MEA Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 97: MEA Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 98: MEA Analgesics Market Share, By Country, 2021 (E)
Figure 99: MEA Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 100: MEA Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 101: MEA Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 102: MEA Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 103: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 104: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 105: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 106: Global Analgesics Market Value Proportion Analysis, By Emerging Countries, 2020
Figure 107: Analgesics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031
Figure 108: U.S. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 109: U.S. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 110: U.S. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 111: U.S. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 112: Canada Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 113: Canada Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 114: Canada. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 115: Canada. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 116: Brazil. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 117: Brazil. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 118: Brazil. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 119: Brazil. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 120: Mexico. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 121: Mexico. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 122: Mexico. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 123: Mexico. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 124: UK. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 125: UK. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 126: UK. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 127: UK. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 128: Germany. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 129: Germany. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 130: Germany. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 131: Germany. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 132: Italy. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 133: Italy. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 134: Italy. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 135: Italy. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 136: France. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 137: France. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 138: France. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 139: France. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 140: Spain. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 141: Spain. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 142: Spain. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 143: Spain. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 144: Russia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 145: Russia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 146: Russia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 147: Russia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 148: BENELUX Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 149: BENELUX Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 150: BENELUX Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 151: BENELUX Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 152: China. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 153: China. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 154: China. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 155: China. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 156: Japan. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 157: Japan. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 158: Japan. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 159: Japan. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 160: South Korea. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 161: South Korea. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 162: South Korea. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 163: South Korea. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 164: India. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 165: India. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 166: India. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 167: India. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 168: Thailand. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 169: Thailand. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 170: Thailand. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 171: Thailand. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 172: Indonesia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 173: Indonesia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 174: Indonesia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 175: Indonesia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 176: Malaysia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 177: Malaysia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 178: Malaysia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 179: Malaysia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 180: Australia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 181: Australia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 182: Australia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 183: Australia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 184: New Zealand Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 185: New Zealand Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 186: New Zealand Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 187: New Zealand Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 188: Turkey Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 189: Turkey Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 190: Turkey Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 191: Turkey Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 192: GCC Countries Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 193: GCC Countries Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 194: GCC Countries Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 195: GCC Countries Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 196: South Africa Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 197: South Africa Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 198: South Africa Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 199: South Africa Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports